Learn More
Medchemexpress LLC Abrocitinib | 1622902-68-4 | MFCD30187577 | 99.3% | 323.41 g·mol⁻¹ | C14H21N5O2S | 25 MG

Supplier: Medchemexpress LLC HY10742925MG
Abrocitinib is a potent, orally active, and selective Janus kinase 1 (JAK1) inhibitor used in preclinical pharmacology. It shows strong JAK1 inhibition (reported IC50 ≈ 29 nM) with reduced activity against JAK2 and TYK2, and is used in in vitro and in vivo models of autoimmune and inflammatory disease.
- Potent and selective JAK1 inhibition.
- Demonstrated cellular activity inhibiting STAT phosphorylation.
- High purity for reproducible experimental results.
- Available as solid and as DMSO solution for flexible dosing.
- Multiple in vivo formulation protocols provided for administration.
- Recommended storage conditions support long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.